Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study

Abstract

Target attainment, tolerance and safety of azlocillin was shown in neonates with EOS using a pharmacokinetic-pharmacodynamic model developed with real-world data.